BNTX - BioNTech SE


103.8
3.040   2.929%

Share volume: 720,655
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%

$100.76
3.04
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024
Fiscal Quarter Q1 2024
Report Date 05-06-2024
Total revenue 202.610 M
Cost of revenue 63.829 M
Gross profit 138.781 M
     
Operating expenses 691.315 M
Selling general and admin 143.209 M
Research and development 548.105 M
Total expenses 755.143 M
     
Operating income -552.533 M
Ebit -552.533 M
Pretax income -358.347 M
     
Income tax -18.036 M
Net income basic -340.311 M
     
Net income -340.311 M